Delivery Order 36C25524D0411-HT009024FG0610050
Award Date
6/26/24
Potential Completion Date
9/30/24
Potential Value
$11K
Federal Agency
Defense Health Agency
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals required for patient care. The $10,826.16 Firm Fixed Price contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) call that runs through September 30, 2024. Sofie is an established provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to various federal agencies, including the Department of Veterans...
This is a federal contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, for the delivery of radiopharmaceuticals. The contract, valued at $36,087.20, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price. The contract has a completion date of September 30, 2024. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals, to various...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., is for the provision of radiopharmaceuticals to the Defense Health Agency (DHA) and supports medical imaging and cancer treatment programs for the Department of Defense. The $100,000.00 firm-fixed-price contract, which is not set-aside, covers the delivery of various radiopharmaceuticals, including positron emission tomography (PET) imaging agents, prostate cancer detection tools, and injectable cancer drugs....
This is a Delivery Order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of radioactive isotopes and PET tracers. The contract has a ceiling value of $339,600.00 and a period of performance through February 28, 2026. This Delivery Order is issued under a larger Indefinite Delivery Vehicle (IDV) contract with the VA VISN 17 network, which facilitates the ongoing procurement of Sofie's specialized radiopharmaceuticals and related services to...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a firm fixed price contract valued at $20,976 by the Defense Health Agency to provide a radiopharmaceutical needed for a prostate cancer patient with metastatic lesions after definitive treatment. The contract has no set-aside designation and requires performance at Sterling, Virginia through September 30, 2022. As the healthcare component of the Department of Defense, this award supports the Defense Health Agency's mission...
This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO., a for-profit manufacturer of molecular diagnostics and therapeutics. The contract, which does not have a set-aside designation, is for the period of October 1, 2019 to September 30, 2020 and has a potential value of $1,906,156.25. Sofie CO. is the prime contractor and a subsidiary of Sofie Biosciences, Inc. The contract provides the VA with PET imaging agents,...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as IBA Molecular, to provide radiopharmaceuticals needed for the treatment of prostate cancer patients with metastatic lesions. The contract has a ceiling value of $21,652.32 and is effective through September 30, 2025. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a for-profit organization specializing in the development, production, and delivery of molecular diagnostics and...
This is a firm fixed-price BPA call order awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, in the amount of $249,249.48. The contract is for the delivery of the LIFE MOLECULAR IMAGING PRODUCT, which includes radiopharmaceuticals, pharmaceuticals, and related services to support medical imaging and cancer treatment programs for the Department of Veterans Affairs (VA) and military treatment facilities. Sofie is an experienced provider of specialized imaging agents,...